NO20000822L - Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander - Google Patents

Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander

Info

Publication number
NO20000822L
NO20000822L NO20000822A NO20000822A NO20000822L NO 20000822 L NO20000822 L NO 20000822L NO 20000822 A NO20000822 A NO 20000822A NO 20000822 A NO20000822 A NO 20000822A NO 20000822 L NO20000822 L NO 20000822L
Authority
NO
Norway
Prior art keywords
substituted
agonists
carboxamides
oxo
receptor ligands
Prior art date
Application number
NO20000822A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000822D0 (no
Inventor
Pamela Albaugh
Robert W Desimone
Gang Liu
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of NO20000822D0 publication Critical patent/NO20000822D0/no
Publication of NO20000822L publication Critical patent/NO20000822L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000822A 1997-08-25 2000-02-18 Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander NO20000822L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25
PCT/US1998/017513 WO1999010347A1 (en) 1997-08-25 1998-08-24 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands

Publications (2)

Publication Number Publication Date
NO20000822D0 NO20000822D0 (no) 2000-02-18
NO20000822L true NO20000822L (no) 2000-04-13

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000822A NO20000822L (no) 1997-08-25 2000-02-18 Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander

Country Status (24)

Country Link
EP (1) EP1007526A1 (hu)
JP (1) JP2001514181A (hu)
KR (1) KR20010023313A (hu)
CN (1) CN1268136A (hu)
AP (1) AP2000001742A0 (hu)
AU (1) AU753800B2 (hu)
BG (1) BG104192A (hu)
BR (1) BR9811362A (hu)
CA (1) CA2301599C (hu)
EG (1) EG21717A (hu)
HU (1) HUP0003258A3 (hu)
IL (1) IL134291A0 (hu)
IS (1) IS5382A (hu)
LV (1) LV12539B (hu)
NO (1) NO20000822L (hu)
NZ (1) NZ502548A (hu)
OA (1) OA11293A (hu)
PE (1) PE130999A1 (hu)
PL (1) PL338783A1 (hu)
SI (1) SI20270A (hu)
SK (1) SK2162000A3 (hu)
TW (1) TW574221B (hu)
WO (1) WO1999010347A1 (hu)
YU (1) YU10500A (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4818000A (en) * 1999-05-06 2000-11-21 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
WO2000071528A1 (en) * 1999-05-25 2000-11-30 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
ES2287170T3 (es) 2000-10-12 2007-12-16 MERCK & CO., INC. Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa.
CA2425625A1 (en) 2000-10-12 2002-07-18 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
DE60138635D1 (de) 2000-10-12 2009-06-18 Merck & Co Inc Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
SK10752003A3 (sk) * 2001-03-01 2004-08-03 Pfizer Products Inc. Použitie inverzných agonistov GABAA v kombinácii s parciálnymi agonistami receptora nikotínu, estrogénom, selektívnymi modulátormi estrogénu alebo vitamínom E pri liečení kognitívnych porúch
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
DE60315796T2 (de) 2002-01-17 2008-06-05 Merck & Co., Inc. Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
JP4494020B2 (ja) 2002-03-15 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
EP2540722B1 (en) * 2006-10-16 2016-06-08 Bionomics Limited Novel anxiolytic compounds
EP2578216A1 (en) * 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Methods of treating fragile x syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204162A1 (es) * 1972-05-08 1975-11-28 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampicilina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
EP1007526A1 (en) 2000-06-14
AU753800B2 (en) 2002-10-31
PL338783A1 (en) 2000-11-20
BR9811362A (pt) 2000-08-22
YU10500A (sh) 2002-10-18
JP2001514181A (ja) 2001-09-11
LV12539A (en) 2000-10-20
AP2000001742A0 (en) 2000-02-24
NO20000822D0 (no) 2000-02-18
WO1999010347A1 (en) 1999-03-04
IL134291A0 (en) 2001-04-30
BG104192A (en) 2001-05-31
LV12539B (en) 2001-01-20
SI20270A (sl) 2000-12-31
CA2301599C (en) 2003-03-25
SK2162000A3 (en) 2001-03-12
CA2301599A1 (en) 1999-03-04
KR20010023313A (ko) 2001-03-26
HUP0003258A2 (en) 2001-03-28
IS5382A (is) 2000-02-22
PE130999A1 (es) 1999-12-16
TW574221B (en) 2004-02-01
CN1268136A (zh) 2000-09-27
NZ502548A (en) 2002-06-28
HUP0003258A3 (en) 2001-05-28
AU9117398A (en) 1999-03-16
OA11293A (en) 2002-11-19
EG21717A (en) 2002-02-27

Similar Documents

Publication Publication Date Title
NO20000822L (no) Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander
CA2175204A1 (en) Certain Fused Pyrrolecarboxanilides; a New Class of GABA Brain Receptor Ligands
DE60018274D1 (de) Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
HUP0000079A2 (hu) Indán- és dihidroindolszármazékok
DE69636670D1 (de) Benzimidazolverbindungen und ihre verwendung als gaba a receptor komplex modulatoren
DK0555391T3 (da) Visse imidazoquinoxaliner; en ny klasse GABA-receptorligander i hjernen
WO1999043660A1 (en) Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
BR9608056A (pt) Compostos de benzimidazol, composições farmacêuticas contendo os compostos e sua utilização.
DE69925462D1 (de) Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande
HUP0303630A2 (hu) Imidazo-pirimidin-származékok, mint GABA receptorok ligandumai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
AU2321597A (en) Novel imidazo{1,5-c}quinazolines; a new class of gaba brain receptor ligands
WO2021046183A1 (en) Methods of treating epilepsy using the same
BR0009539A (pt) composto, composição farmacêutica, método para tratamento ou prevenção de uma doença ou distúrbio associado com agonismo patogênico, agonismo inverso ou antagonismo do receptor gaba a, uso de um composto, método para localizar receptores gaba a em uma amostra de tecido, método para alterar a atividade transdutora de sinal de receptores gaba a, método para o tratamento ou prevenção de distúrbios psicológicos associados com modulação do complexo receptor gaba a, e, processo para a preparação de um composto
ATE482931T1 (de) Somatostatinrezeptor-1- und/oder -4-selektive agonisten und antagonisten
CA2223936A1 (en) Novel substituted aryl and cycloalkyl imidazolones; a new class of gaba brain receptor ligands
DE69926378D1 (de) Oxo-pyridoimidazol-carboxamide: gaba-rezeptor-liganden im gehirn
MX9709771A (es) Nuevas aril y cicloalquil imidazolonas substituidas, una clase de ligandos receptores de acido gamma-aminobutirico del cerebro.
CA2249562A1 (en) Certain fused pyrrolecarboxamides as gaba brain receptor ligands
BR112019028078A2 (pt) derivados de 2-oxo-1,3-oxazolidinil imidazotiadiazol
AR007742A1 (es) Pirrolcarboxanilidas fusionadas; una nueva clase de ligandos receptores gaba del cerebro.
TH35993A (th) ฟิวส์ พิร์โรลคาร์บอกแซนิไลด์
BR9807840A (pt) Derivados de 4-aminoalcóxi-1,3-dihidrobenzoimidazol-2-tionas, sua preparação e seu uso como agonistas de auto-receptor de dopamina (d2)
MXPA01006351A (en) Diphenylurea compounds
TH52364A (th) ปรปักษ์ของตัวรับเบนซอกซาซิโนนโดพามีน d4

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application